2022 Chrysler Pacifica Touring L on 2040-cars

Auto blog

Chrysler killing off the 200 Convertible, Dodge Avenger

When Chrysler rolled out the first-generation 200 to replace the Sebring range in 2010, it included replacements for both the sedan and the convertible. The Sebring Coupe, however, was left out of the mix. And now that the second-generation Chrysler 200 is descending upon us, Auburn Hills is paring things down even further. But this time, it's the convertible that reportedly isn't making the cut. Shame, too, since the rendering above shows what could have been quite an attractive droptop.
As our compatriots at Edmunds point out, sales of the convertible model accounted for less than five percent of overall Chrysler 200 sales, and at those numbers, the considerable cost of engineering a new drop-top couldn't be justified. With the Toyota Camry Solara and Volkswagen Eos also gone from the market (well, the VW isn't gone quite yet), the discontinuation of the Chrysler 200 Convertible leaves the affordable convertible segment largely to the sportier likes of the Ford Mustang and Chevy Camaro and smaller European offerings like the Mini Cooper and VW Beetle.
The Chrysler 200 Convertible isn't the only derivative being left behind with the new model: so too is the Dodge Avenger. That will leave a glaring hole in the Dodge lineup, with nothing to bridge the gap between the compact Dart and the larger Charger. Whether the Dodge brand has any plans to replace the Avenger with another model, not to be based on the 200, remains to be seen.

Fiat Chrysler says it did not know about Marchionne's illness

ZURICH/MILAN — Fiat Chrysler said it knew nothing about the medical condition of Sergio Marchionne after a Swiss hospital said on Thursday it had been treating the deceased chief executive for more than a year. "Due to medical privacy, the company had no knowledge of the facts relating to Mr. Marchionne's health," a Fiat Chrysler spokesman said. Questions have been raised about how long Marchionne, who died on Wednesday, was ill and how much the company knew before it made the situation public. Marchionne rescued Fiat and Chrysler from bankruptcy after taking the wheel of the Italian carmaker in 2004 and he multiplied Fiat's value 11 times through 14 years of canny dealmaking. He was due to step down at FCA in April next year. "The company was made aware that Mr. Marchionne had undergone shoulder surgery and released a statement about this," the spokesperson said. "On Friday, July 20, the company was made aware with no detail by Mr. Marchionne's family of the serious deterioration in Mr. Marchionne's condition and that as a result he would be unable to return to work. The company promptly took and announced the appropriate action the following day." Asked whether the scope of the statement included the board and the chairman, the company declined to comment. In emailed comments, Marchionne's family confirmed the companies had not been aware of his health conditions. "At the end of last week FCA was made aware Sergio Marchionne would no longer be able to return to work without mentioning any further details," the family said. The announcement of the death of Marchionne, 66, one of the auto industry's most tenacious and respected CEOs, drew tributes from rivals and tears from his closest colleagues on Wednesday. University Hospital Zurich said earlier on Thursday Marchionne had been treated for a serious illness for more than a year before his death. Marchionne had fallen gravely ill after what the company had described as shoulder surgery at a Zurich hospital. He was replaced as chief executive last weekend after Fiat Chrysler (FCA) said his condition had worsened. "Mr. Sergio Marchionne was a patient at USZ. Due to serious illness, he had been the recipient of recurring treatment for more than a year," the hospital said in a statement. "Although all the options offered by cutting-edge medicine were utilized, Mr.

FCA, Ford idle plants due to semiconductor shortage

DETROIT (Reuters) - Ford and FCA will become the latest automakers to idle production facilities due to a semiconductor shortage. Ford's Louisville Assembly Plant in Kentucky will idle for a week, borrowing a down period from later in the year to compensate. Per Automotive News, FCA is idling its Brampton facility in Ontario, Canada, and one other site which has not yet been identified.  Louisville Assembly is the production site for the Ford Escape and Lincoln Corsair SUVs; Brampton Assembly produces the Chrysler 300, Dodge Charger and Dodge Challenger for FCA.  A Ford spokeswoman, who declined to identify the semiconductor supplier, confirmed the temporary shutdown to Reuters. In this, FCA and Ford join Nissan and potentially Honda in idling production in the wake of the shortage, which also hit Volkswagen late last year. The shortages are being blamed on consumer demand for silicon after production slowdowns resulting from the coronavirus pandemic. Volkswagen said it had to adjust production schedules in China, Europe and North America to compensate.  Nissan said it planned to reduce production of the Note, a hybrid electric car, at its Oppama Plant in Kanagawa prefecture, Japan, but did not give details of the scale of the output cut. The Nikkei newspaper reported that Nissan would slash its Note production at Oppama to about 5,000 units in January, from an initially planned 15,000 units. "A global shortage of semiconductors has affected parts procurement in the auto sector. As a result of this shortage, the Oppama Plant in Japan will adjust production in January, reducing production of the Nissan NOTE," Nissan said in a statement. (This article contains reporting from Reuters.)     Auto News Plants/Manufacturing UAW/Unions Chrysler Dodge Ford